Relationship between maternal methadone dosage and neonatal withdrawal

Area of Science:

• Neonatal Abstinence Syndrome
• Pharmacology
• Obstetrics

Background:

• Opioid addiction in pregnant women presents significant risks to neonates.
• Neonatal narcotic withdrawal is a serious concern requiring careful management.
• Methadone maintenance therapy is a common treatment for opioid addiction during pregnancy.

Purpose of the Study:

• To investigate the relationship between maternal methadone dosage and neonatal narcotic withdrawal.
• To determine if maternal methadone dosage affects the duration and severity of neonatal withdrawal symptoms.

Main Methods:

• Retrospective cohort study of pregnant women with opioid addiction.
• Analysis of neonatal withdrawal indices based on maternal methadone dosage in the final week of pregnancy.
• Inclusion of data on maternal drug screening and neonatal opioid testing.

Main Results:

• Higher maternal methadone dosages were associated with increased rates of neonatal withdrawal treatment (90% at >=40mg vs 12% at <20mg).
• Methadone dosage strongly correlated with neonatal hospitalization duration and abstinence scores (P <.001).
• Heroin supplementation increased withdrawal likelihood but did not alter the methadone dose-response relationship.

Conclusions:

• Maternal methadone dosage is a key factor influencing neonatal withdrawal.
• Lowering maternal methadone dosage may reduce neonatal withdrawal incidence and severity.
• The dose-response relationship between methadone and neonatal withdrawal is significant, independent of heroin supplementation.